TY - JOUR
KW - Buprenorphine/adverse effects/pharmacology/therapeutic use
KW - Child Development/drug effects
KW - Female
KW - Fetus/drug effects
KW - Humans
KW - Infant, Newborn
KW - Length of Stay
KW - Methadone/therapeutic use
KW - Milk, Human/chemistry
KW - Morphine/therapeutic use
KW - Narcotic Antagonists/adverse effects/pharmacology/therapeutic use
KW - Neonatal Abstinence Syndrome/drug therapy
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/urine
KW - Pain Management/methods
KW - Patient Dropouts
KW - Pregnancy
KW - Pregnancy Complications/drug therapy
KW - Prenatal Exposure Delayed Effects/therapy
KW - Randomized Controlled Trials as Topic
KW - Substance Abuse Detection
KW - Treatment Outcome
AU - H. E. Jones
AU - S. H. Heil
AU - A. Baewert
AU - A. M. Arria
AU - K. Kaltenbach
AU - P. R. Martin
AU - M. G. Coyle
AU - P. Selby
AU - S. M. Stine
AU - G. Fischer
A1 - 
BT - Addiction (Abingdon, England)
C5 - Healthcare Disparities; Opioids & Substance Use
CP - Suppl. 1
CY - England
IS - Suppl. 1
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2012
SN - 1360-0443; 0965-2140
SP - 5
EP - 27
EP - 
T1 - Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review
T2 - Addiction (Abingdon, England)
TI - Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 23106923
VL - 107
VO - 1360-0443; 0965-2140
Y1 - 2012
ER -